Brain Biomarkers Market

Brain Biomarkers Market By Product Type, Disease Indication, Application, End use & Region - Forecast 2022 – 2032

Market Insights on Brain Biomarkers covering sales outlook, demand forecast and up-to-date key trends

Request Sample

Brain Biomarkers Market Snapshot (2022-2032)

[250 Pages Report] The global brain biomarkers market is anticipated to exhibit growth at a CAGR of 14.3% in the forecast period from 2022 to 2032. It is set to reach US$ 8.3 Billion in 2022 and US$ 11.5 Billion in 2032. The rising prevalence of various neurological diseases, such as brain tumors, migraines, epilepsy, and dementia is projected to drive the sales of brain biomarkers in future years.

Report Attribute	Details
Brain Biomarkers Market Estimated Base Year Value (2021)	US$ 7.1 Billion
Brain Biomarkers Market Expected Market Value (2022)	US$ 8.3 Billion
Brain Biomarkers Market Anticipated Forecast Value (2032)	US$ 11.5 Billion
Brain Biomarkers Market Projected Growth Rate (2022-2032)	14.3% CAGR

Biomarkers are referred to as molecules that indicate the presence of a dysfunction or disease. These are becoming increasingly important for monitoring disease progression, selecting the best treatments, and confirming diagnoses.

Neurological biomarkers are mainly present in Cerebrospinal Fluid (CSF) and rarely in blood. These can be studied by using CSF, but require an invasive lumbar puncture procedure.

Biomarker signatures are considered to be another powerful tool for studying neurological conditions and diseases. These are detected with the help of panels of high-quality antibodies.

The development of genomic biomarkers is projected to create new opportunities for the introduction of diagnostics that are based on a person’s specific genetic variations. Genomic biomarkers are also expected to help in the creation of personalized medicines.

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Which are Some Major Factors Spurring Growth of the Brain Biomarkers Market

The ongoing technological advancement in the field of biomarkers and the emergence of biomarker signatures are expected to make neurological diseases more treatable. This is further expected to result in the early diagnosis, faster drug development, and non-invasive testing.

The launch of digital biomarkers by key players is set to deliver numerous pharmaceutical companies supplemental and contextual information to conclude clinical trials efficiently. Besides, government funding to accelerate research and development activities in various countries is expected to propel the demand for brain biomarkers in the assessment period.

Which Factors May Restrain the Brain Biomarkers Market Growth

The usage of brain biomarkers is limited to researchers for better understanding the disease progression. Several pharmaceutical and pathology companies worldwide are also using these to rapidly develop new therapeutics for neurodegenerative disorders. The lack of availability of commercial or direct-to-consumer tests may hamper the brain biomarkers market size in the near future.

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Why is North America Projected to Dominate the Brain Biomarkers Market

North America is anticipated to lead in terms of the brain biomarkers market share during the forthcoming years. This growth is attributable to the rising research funding by regulatory bodies and the surging acceptance of biomarkers for drug development purposes in the U.S. and Canada.

The increasing prevalence of various neurological diseases across these developed countries is another significant factor that is estimated to augur well for the market.

As per the Centers for Disease Control and Prevention (CDC), at present, nearly 5.8 million people have Alzheimer’s disease in the U.S. Cases of Alzheimer’s disease are expected to reach 14 million by 2060 in the country. These numbers are projected to grow at a fast pace, thereby propelling the North America market.

How is the Asia Pacific Brain Biomarkers Market Progressing

Asia Pacific is likely to exhibit a CAGR of 15.4% in the forecast period from 2022 to 2032. The rising number of clinical trials that are being conducted in China, Japan, India, and South Korea is projected to drive the Asia Pacific brain biomarkers market growth in future years.

The surging demand for targeted drugs to treat conditions associated with the central nervous system is another vital factor that is anticipated to augment the growth in the regional market. According to the National Health Portal, in India, the prevalence of dementia is set to be around 2.7%. This condition poses a great challenge in the country owing to the surging geriatric population. This factor is also expected to fuel the regional market.

Market Competition

Majority of the key players operating in the global market are striving to incorporate the latest technologies to make it easier for researchers to track the condition of the brain by measuring its molecules. They are consistently developing innovative brain testing methods to provide new treatment options and enable faster diagnosis. Meanwhile, a few other key players are aiming to invest huge sums in clinical trials to boost new product development.

Some of the leading companies present in the global brain biomarkers market include Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, Johnson & Johnson, Natus Medical, F. Hoffmann-La Roche Ltd., Qiagen N.V., Nexus-DX, and NeuroVista among others.

Report Scope

Report Attribute	Details
Growth Rate	CAGR of 14.3% from 2022 to 2032
Base Year for Estimation	2021
Historical Data	2015-2020
Forecast Period	2022-2032
Quantitative Units	Revenue in USD Million and CAGR from 2022-2032
Report Coverage	Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis
Segments Covered	Product Type Disease Indication Application End User Region
Regions Covered	North America Latin America Western Europe Eastern Europe APEJ Japan Middle East and Africa
Key Countries Profiled	U.S Canada Brazil Argentina Germany U.K France Spain Italy Nordics BENELUX Australia & New Zealand China India ASEAN GCC South Africa
Key Companies Profiled	Siemens Healthineers Electrical Geodesics Lifesign LLC Advanced Brain Monitoring BrainScope GE Healthcare Johnson & Johnson Natus Medical F. Hoffmann-La Roche Ltd. Qiagen N.V. Nexus-DX NeuroVista
Customization	Available Upon Request

Key Segments Profiled in the Brain Biomarkers Industry Survey

By Product Type:

Biomarker Test Kits
Biomarker Analyzers

By Disease Indication:

Stroke
MND & ALS
Alzheimer’s Disease & Other Dementias
Parkinson’s Disease
Huntington’s Disease

By Application:

Diagnosis
Drug Discovery and Development
Others

By End User:

Hospitals
Research Laboratories
Ambulatory Surgical Centers
Diagnostic Laboratories

By Region:

North America
Latin America
Western Europe
Eastern Europe
APEJ
Japan
Middle East and Africa

Frequently Asked Questions

At what rate will the brain biomarkers market grow?

The global brain biomarkers market is anticipated to surpass US$ 11.5 Billion in 2032.

Which region is set to lead the brain biomarkers market?

North America is set to lead the brain biomarkers market in the forecast period.

Which are some of the renowned companies in the brain biomarkers market?

Siemens Healthineers, Electrical Geodesics, Lifesign LLC, Advanced Brain Monitoring, BrainScope, GE Healthcare, and Johnson & Johnson are some of the renowned companies in the brain biomarkers market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand-side Trends

1.3. Supply-side Trends

1.4. Technology Roadmap Analysis

1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Background

3.1. Market Dynamics

3.1.1. Drivers

3.1.2. Restraints

3.1.3. Opportunity

3.1.4. Trends

3.2. Scenario Forecast

3.2.1. Demand in Optimistic Scenario

3.2.2. Demand in Likely Scenario

3.2.3. Demand in Conservative Scenario

3.3. Opportunity Map Analysis

3.4. Investment Feasibility Matrix

3.5. Value Chain Analysis

3.5.1. Profit Margin Analysis

3.5.2. Service Providers

3.6. PESTLE and Porter’s Analysis

3.7. Regulatory Landscape

3.7.1. By Key Regions

3.7.2. By Key Countries

3.8. Regional Parent Market Outlook

4. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast, 2022-2032

4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021

4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032

4.2.1. Y-o-Y Growth Trend Analysis

4.2.2. Absolute $ Opportunity Analysis

5. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Biomarkers

5.1. Introduction / Key Findings

5.2. Historical Market Size Value (US$ Mn) Analysis By Biomarkers, 2017-2021

5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Biomarkers, 2022-2032

5.3.1. Genomics Biomarkers

5.3.2. Proteomic Biomarkers

5.3.3. Metabolomics Biomarkers

5.3.4. Imaging Biomarkers

5.3.5. Other Biomarkers

5.4. Y-o-Y Growth Trend Analysis By Biomarkers, 2017-2021

5.5. Absolute $ Opportunity Analysis By Biomarkers, 2022-2032

Deep-dive segmentation will be available in the sample on request

6. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Indication

6.1. Introduction / Key Findings

6.2. Historical Market Size Value (US$ Mn) Analysis By Indication, 2017-2021

6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Indication, 2022-2032

6.3.1. Alzheimer’s Disease

6.3.2. Parkinson’s Disease

6.3.3. Huntington’s Disease

6.3.4. Schizophrenia

6.3.5. Depression

6.3.6. Multiple Sclerosis

6.3.7. Spinal Muscular Atrophy

6.4. Y-o-Y Growth Trend Analysis By Indication, 2017-2021

6.5. Absolute $ Opportunity Analysis By Indication, 2022-2032

Deep-dive segmentation will be available in the sample on request

7. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By End Users

7.1. Introduction / Key Findings

7.2. Historical Market Size Value (US$ Mn) Analysis By End Users, 2017-2021

7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End Users, 2022-2032

7.3.1. Academic & Research Institutes

7.3.2. Diagnostic Laboratories

7.3.3. Hospitals

7.4. Y-o-Y Growth Trend Analysis By End Users, 2017-2021

7.5. Absolute $ Opportunity Analysis By End Users, 2022-2032

Deep-dive segmentation will be available in the sample on request

8. Global Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Region

8.1. Introduction

8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021

8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032

8.3.1. North America

8.3.2. Latin America

8.3.3. Europe

8.3.4. East Asia

8.3.5. South Asia & Pacific

8.3.6. MEA

8.4. Market Attractiveness Analysis By Region

9. North America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

9.2.1. By Country

9.2.1.1. U.S.

9.2.1.2. Canada

9.2.2. By Biomarkers

9.2.3. By Indication

9.2.4. By End Users

9.3. Market Attractiveness Analysis

9.3.1. By Country

9.3.2. By Biomarkers

9.3.3. By Indication

9.3.4. By End Users

9.4. Key Takeaways

10. Latin America Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

10.2.1. By Country

10.2.1.1. Mexico

10.2.1.2. Brazil

10.2.1.3. Rest of Latin America

10.2.2. By Biomarkers

10.2.3. By Indication

10.2.4. By End Users

10.3. Market Attractiveness Analysis

10.3.1. By Country

10.3.2. By Biomarkers

10.3.3. By Indication

10.3.4. By End Users

10.4. Key Takeaways

11. Europe Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

11.2.1. By Country

11.2.1.1. Germany

11.2.1.2. Italy

11.2.1.3. France

11.2.1.4. U.K.

11.2.1.5. Spain

11.2.1.6. BENELUX

11.2.1.7. Russia

11.2.1.8. Rest of Europe

11.2.2. By Biomarkers

11.2.3. By Indication

11.2.4. By End Users

11.3. Market Attractiveness Analysis

11.3.1. By Country

11.3.2. By Biomarkers

11.3.3. By Indication

11.3.4. By End Users

11.4. Key Takeaways

12. East Asia Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

12.2.1. By Country

12.2.1.1. China

12.2.1.2. Japan

12.2.1.3. South Korea

12.2.2. By Biomarkers

12.2.3. By Indication

12.2.4. By End Users

12.3. Market Attractiveness Analysis

12.3.1. By Country

12.3.2. By Biomarkers

12.3.3. By Indication

12.3.4. By End Users

12.4. Key Takeaways

13. South Asia & Pacific Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

13.2.1. By Country

13.2.1.1. India

13.2.1.2. ASEAN

13.2.1.3. Australia and New Zealand

13.2.1.4. Rest of South Asia & Pacific

13.2.2. By Biomarkers

13.2.3. By Indication

13.2.4. By End Users

13.3. Market Attractiveness Analysis

13.3.1. By Country

13.3.2. By Biomarkers

13.3.3. By Indication

13.3.4. By End Users

13.4. Key Takeaways

14. MEA Brain Biomarkers Market Analysis 2017-2021 and Forecast 2022-2032, By Country

14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021

14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032

14.2.1. By Country

14.2.1.1. GCC Countries

14.2.1.2. Turkey

14.2.1.3. South Africa

14.2.1.4. Rest of MEA

14.2.2. By Biomarkers

14.2.3. By Indication

14.2.4. By End Users

14.3. Market Attractiveness Analysis

14.3.1. By Country

14.3.2. By Biomarkers

14.3.3. By Indication

14.3.4. By End Users

14.4. Key Takeaways

15. Key Countries Brain Biomarkers Market Analysis

15.1. U.S.

15.1.1. Pricing Analysis

15.1.2. Market Share Analysis, 2021

15.1.2.1. By Biomarkers

15.1.2.2. By Indication

15.1.2.3. By End Users

15.2. Canada

15.2.1. Pricing Analysis

15.2.2. Market Share Analysis, 2021

15.2.2.1. By Biomarkers

15.2.2.2. By Indication

15.2.2.3. By End Users

15.3. Mexico

15.3.1. Pricing Analysis

15.3.2. Market Share Analysis, 2021

15.3.2.1. By Biomarkers

15.3.2.2. By Indication

15.3.2.3. By End Users

15.4. Brazil

15.4.1. Pricing Analysis

15.4.2. Market Share Analysis, 2021

15.4.2.1. By Biomarkers

15.4.2.2. By Indication

15.4.2.3. By End Users

15.5. Germany

15.5.1. Pricing Analysis

15.5.2. Market Share Analysis, 2021

15.5.2.1. By Biomarkers

15.5.2.2. By Indication

15.5.2.3. By End Users

15.6. Italy

15.6.1. Pricing Analysis

15.6.2. Market Share Analysis, 2021

15.6.2.1. By Biomarkers

15.6.2.2. By Indication

15.6.2.3. By End Users

15.7. France

15.7.1. Pricing Analysis

15.7.2. Market Share Analysis, 2021

15.7.2.1. By Biomarkers

15.7.2.2. By Indication

15.7.2.3. By End Users

15.8. U.K.

15.8.1. Pricing Analysis

15.8.2. Market Share Analysis, 2021

15.8.2.1. By Biomarkers

15.8.2.2. By Indication

15.8.2.3. By End Users

15.9. Spain

15.9.1. Pricing Analysis

15.9.2. Market Share Analysis, 2021

15.9.2.1. By Biomarkers

15.9.2.2. By Indication

15.9.2.3. By End Users

15.10. BENELUX

15.10.1. Pricing Analysis

15.10.2. Market Share Analysis, 2021

15.10.2.1. By Biomarkers

15.10.2.2. By Indication

15.10.2.3. By End Users

15.11. Russia

15.11.1. Pricing Analysis

15.11.2. Market Share Analysis, 2021

15.11.2.1. By Biomarkers

15.11.2.2. By Indication

15.11.2.3. By End Users

15.12. China

15.12.1. Pricing Analysis

15.12.2. Market Share Analysis, 2021

15.12.2.1. By Biomarkers

15.12.2.2. By Indication

15.12.2.3. By End Users

15.13. Japan

15.13.1. Pricing Analysis

15.13.2. Market Share Analysis, 2021

15.13.2.1. By Biomarkers

15.13.2.2. By Indication

15.13.2.3. By End Users

15.14. South Korea

15.14.1. Pricing Analysis

15.14.2. Market Share Analysis, 2021

15.14.2.1. By Biomarkers

15.14.2.2. By Indication

15.14.2.3. By End Users

15.15. India

15.15.1. Pricing Analysis

15.15.2. Market Share Analysis, 2021

15.15.2.1. By Biomarkers

15.15.2.2. By Indication

15.15.2.3. By End Users

15.16. ASEAN

15.16.1. Pricing Analysis

15.16.2. Market Share Analysis, 2021

15.16.2.1. By Biomarkers

15.16.2.2. By Indication

15.16.2.3. By End Users

15.17. Australia and New Zealand

15.17.1. Pricing Analysis

15.17.2. Market Share Analysis, 2021

15.17.2.1. By Biomarkers

15.17.2.2. By Indication

15.17.2.3. By End Users

15.18. GCC Countries

15.18.1. Pricing Analysis

15.18.2. Market Share Analysis, 2021

15.18.2.1. By Biomarkers

15.18.2.2. By Indication

15.18.2.3. By End Users

15.19. Turkey

15.19.1. Pricing Analysis

15.19.2. Market Share Analysis, 2021

15.19.2.1. By Biomarkers

15.19.2.2. By Indication

15.19.2.3. By End Users

15.20. South Africa

15.20.1. Pricing Analysis

15.20.2. Market Share Analysis, 2021

15.20.2.1. By Biomarkers

15.20.2.2. By Indication

15.20.2.3. By End Users

16. Market Structure Analysis

16.1. Competition Dashboard

16.2. Competition Benchmarking

16.3. Market Share Analysis of Top Players

16.3.1. By Regional

16.3.2. By Biomarkers

16.3.3. By Indication

16.3.4. By End Users

17. Competition Analysis

17.1. Competition Deep Dive

17.1.1. Merck KGaA

17.1.1.1. Overview

17.1.1.2. Product Portfolio

17.1.1.3. Profitability by Market Segments

17.1.1.4. Sales Footprint

17.1.1.5. Strategy Overview

17.1.1.5.1. Marketing Strategy

17.1.1.5.2. Product Strategy

17.1.1.5.3. Channel Strategy

17.1.2. Quanterix

17.1.2.1. Overview

17.1.2.2. Product Portfolio

17.1.2.3. Profitability by Market Segments

17.1.2.4. Sales Footprint

17.1.2.5. Strategy Overview

17.1.2.5.1. Marketing Strategy

17.1.2.5.2. Product Strategy

17.1.2.5.3. Channel Strategy

17.1.3. Myriad RBM

17.1.3.1. Overview

17.1.3.2. Product Portfolio

17.1.3.3. Profitability by Market Segments

17.1.3.4. Sales Footprint

17.1.3.5. Strategy Overview

17.1.3.5.1. Marketing Strategy

17.1.3.5.2. Product Strategy

17.1.3.5.3. Channel Strategy

17.1.4. QIAGEN

17.1.4.1. Overview

17.1.4.2. Product Portfolio

17.1.4.3. Profitability by Market Segments

17.1.4.4. Sales Footprint

17.1.4.5. Strategy Overview

17.1.4.5.1. Marketing Strategy

17.1.4.5.2. Product Strategy

17.1.4.5.3. Channel Strategy

17.1.5. ADx NeuroSciences NV

17.1.5.1. Overview

17.1.5.2. Product Portfolio

17.1.5.3. Profitability by Market Segments

17.1.5.4. Sales Footprint

17.1.5.5. Strategy Overview

17.1.5.5.1. Marketing Strategy

17.1.5.5.2. Product Strategy

17.1.5.5.3. Channel Strategy

17.1.6. Thermo Fisher Scientific

17.1.6.1. Overview

17.1.6.2. Product Portfolio

17.1.6.3. Profitability by Market Segments

17.1.6.4. Sales Footprint

17.1.6.5. Strategy Overview

17.1.6.5.1. Marketing Strategy

17.1.6.5.2. Product Strategy

17.1.6.5.3. Channel Strategy

17.1.7. BioAgilytix

17.1.7.1. Overview

17.1.7.2. Product Portfolio

17.1.7.3. Profitability by Market Segments

17.1.7.4. Sales Footprint

17.1.7.5. Strategy Overview

17.1.7.5.1. Marketing Strategy

17.1.7.5.2. Product Strategy

17.1.7.5.3. Channel Strategy

17.1.8. ACOBIOM

17.1.8.1. Overview

17.1.8.2. Product Portfolio

17.1.8.3. Profitability by Market Segments

17.1.8.4. Sales Footprint

17.1.8.5. Strategy Overview

17.1.8.5.1. Marketing Strategy

17.1.8.5.2. Product Strategy

17.1.8.5.3. Channel Strategy

17.1.9. Banyan Biomarkers, Inc.

17.1.9.1. Overview

17.1.9.2. Product Portfolio

17.1.9.3. Profitability by Market Segments

17.1.9.4. Sales Footprint

17.1.9.5. Strategy Overview

17.1.9.5.1. Marketing Strategy

17.1.9.5.2. Product Strategy

17.1.9.5.3. Channel Strategy

17.1.10. Olink Biosciences

17.1.10.1. Overview

17.1.10.2. Product Portfolio

17.1.10.3. Profitability by Market Segments

17.1.10.4. Sales Footprint

17.1.10.5. Strategy Overview

17.1.10.5.1. Marketing Strategy

17.1.10.5.2. Product Strategy

17.1.10.5.3. Channel Strategy

17.1.11. Illumina, Inc.

17.1.11.1. Overview

17.1.11.2. Product Portfolio

17.1.11.3. Profitability by Market Segments

17.1.11.4. Sales Footprint

17.1.11.5. Strategy Overview

17.1.11.5.1. Marketing Strategy

17.1.11.5.2. Product Strategy

17.1.11.5.3. Channel Strategy

18. Assumptions & Acronyms Used

19. Research Methodology

List of Tables

Table 1: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Region, 2017-2032

Table 2: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 3: Global Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 4: Global Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 5: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 6: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 7: North America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 8: North America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 9: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 10: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 11: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 12: Latin America Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 13: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 14: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 15: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 16: Europe Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 17: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 18: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 19: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 20: East Asia Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 21: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 22: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 23: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 24: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 25: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Country, 2017-2032

Table 26: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Biomarkers, 2017-2032

Table 27: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by Indication, 2017-2032

Table 28: MEA Brain Biomarkers Market Value (US$ Mn) Forecast by End Users, 2017-2032

Table 29: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Table 30: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Table 31: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Table 32: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Table 33: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Table 34: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Table 35: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Table 36: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Table 37: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Table 38: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Table 39: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032

Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

List of Charts

Figure 1: Global Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 2: Global Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 3: Global Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 4: Global Brain Biomarkers Market Value (US$ Mn) by Region, 2022-2032

Figure 5: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Region, 2017-2032

Figure 6: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Region, 2022-2032

Figure 7: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Region, 2022-2032

Figure 8: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 9: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 10: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 11: Global Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 12: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 13: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 14: Global Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 15: Global Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 16: Global Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 17: Global Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 18: Global Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 19: Global Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 20: Global Brain Biomarkers Market Attractiveness by Region, 2022-2032

Figure 21: North America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 22: North America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 23: North America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 24: North America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 25: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 26: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 27: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 28: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 29: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 30: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 31: North America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 32: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 33: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 34: North America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 35: North America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 36: North America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 37: North America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 38: North America Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 39: North America Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 40: North America Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 41: Latin America Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 42: Latin America Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 43: Latin America Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 44: Latin America Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 45: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 46: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 47: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 48: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 49: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 50: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 51: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 52: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 53: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 54: Latin America Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 55: Latin America Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 56: Latin America Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 57: Latin America Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 58: Latin America Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 59: Latin America Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 60: Latin America Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 61: Europe Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 62: Europe Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 63: Europe Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 64: Europe Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 65: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 66: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 67: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 68: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 69: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 70: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 71: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 72: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 73: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 74: Europe Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 75: Europe Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 76: Europe Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 77: Europe Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 78: Europe Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 79: Europe Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 80: Europe Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 81: East Asia Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 82: East Asia Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 83: East Asia Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 84: East Asia Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 85: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 86: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 87: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 88: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 89: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 90: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 91: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 92: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 93: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 94: East Asia Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 95: East Asia Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 96: East Asia Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 97: East Asia Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 98: East Asia Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 99: East Asia Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 100: East Asia Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 101: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 102: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 103: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 104: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 105: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 106: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 107: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 108: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 109: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 110: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 111: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 112: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 113: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 114: South Asia & Pacific Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 115: South Asia & Pacific Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 116: South Asia & Pacific Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 117: South Asia & Pacific Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 118: South Asia & Pacific Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 119: South Asia & Pacific Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 120: South Asia & Pacific Brain Biomarkers Market Attractiveness by Country, 2022-2032

Figure 121: MEA Brain Biomarkers Market Value (US$ Mn) by Biomarkers, 2022-2032

Figure 122: MEA Brain Biomarkers Market Value (US$ Mn) by Indication, 2022-2032

Figure 123: MEA Brain Biomarkers Market Value (US$ Mn) by End Users, 2022-2032

Figure 124: MEA Brain Biomarkers Market Value (US$ Mn) by Country, 2022-2032

Figure 125: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Country, 2017-2032

Figure 126: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Country, 2022-2032

Figure 127: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Country, 2022-2032

Figure 128: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Biomarkers, 2017-2032

Figure 129: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Biomarkers, 2022-2032

Figure 130: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Biomarkers, 2022-2032

Figure 131: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by Indication, 2017-2032

Figure 132: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by Indication, 2022-2032

Figure 133: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by Indication, 2022-2032

Figure 134: MEA Brain Biomarkers Market Value (US$ Mn) Analysis by End Users, 2017-2032

Figure 135: MEA Brain Biomarkers Market Value Share (%) and BPS Analysis by End Users, 2022-2032

Figure 136: MEA Brain Biomarkers Market Y-o-Y Growth (%) Projections by End Users, 2022-2032

Figure 137: MEA Brain Biomarkers Market Attractiveness by Biomarkers, 2022-2032

Figure 138: MEA Brain Biomarkers Market Attractiveness by Indication, 2022-2032

Figure 139: MEA Brain Biomarkers Market Attractiveness by End Users, 2022-2032

Figure 140: MEA Brain Biomarkers Market Attractiveness by Country, 2022-2032